Hospital
Nassau Health Care Corporation
Nassau Health Care Corporation was paid $42.17M by Medicaid between Jan 2018 and Dec 2024, across 397 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.
33Billing provider infoNASSAU HEALTH CARE CORPORATION
EAST MEADOW, NY 11554
EAST MEADOW, NY 11554
33aNPI1801857172assigned 03/28/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$42.17M
24GClaims865,629
24DCodes billed397
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#37 of 231
Median peer was paid$561K
This provider vs. median75×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MILLER, RICHARD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,633 | $623K | |
| 2019 | 71,647 | $2.93M | |
| 2020 | 145,774 | $6.24M | |
| 2021 | 172,860 | $8.21M | |
| 2022 | 169,234 | $8.71M | |
| 2023 | 174,420 | $8.94M | |
| 2024incomplete | 119,061 | $6.51M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 47,472 | 40,958 | $6.60M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 66,574 | 55,855 | $6.03M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.3% | 29,863 | 24,606 | $3.08M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.8% | 18,988 | 17,788 | $2.88M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.6% | 12,944 | 12,299 | $1.95M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.4% | 10,285 | 9,512 | $1.42M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 3.3% | 11,338 | 4,839 | $1.41M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.8% | 10,181 | 9,836 | $1.16M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 10,382 | 8,723 | $891K |
| G0378 | Hospital observation service, per hour | 1.7% | 1,004 | 976 | $736K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.7% | 11,513 | 10,147 | $719K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.5% | 4,203 | 3,467 | $639K |
385 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.4% | 4,044 | $589K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.4% | 6,754 | $588K |
| 80053 | Comprehensive metabolic panel | 1.2% | 32,220 | $527K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 3,474 | $455K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.0% | 4,719 | $435K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 7,605 | $400K |
| 99443 | <1% | 5,571 | $385K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,492 | $344K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 3,096 | $339K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 6,527 | $315K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 3,225 | $314K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 512 | $310K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 3,859 | $306K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,204 | $286K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,511 | $272K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,688 | $263K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,478 | $260K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 564 | $253K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 7,838 | $227K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,935 | $219K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,578 | $219K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 4,091 | $216K |
| 92551 | <1% | 4,844 | $214K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,462 | $205K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 255 | $203K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 4,531 | $198K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,019 | $182K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,355 | $178K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 2,325 | $174K |
| 90671 | <1% | 921 | $164K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 239 | $148K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 5,397 | $126K |
| 80061 | Lipid panel | <1% | 12,676 | $125K |
| 90651 | <1% | 1,009 | $119K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,792 | $114K |
| 86850 | <1% | 4,398 | $107K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,093 | $103K |
| 80050 | General health panel | <1% | 5,323 | $97K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 2,006 | $95K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 10,615 | $93K |
| 92201 | <1% | 1,657 | $93K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,606 | $92K |
| 90670 | <1% | 3,405 | $91K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,346 | $91K |
| Q3014 | Telehealth originating site facility fee | <1% | 5,571 | $90K |
| 99442 | <1% | 1,426 | $85K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,720 | $84K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 11,259 | $80K |
| 82803 | <1% | 6,288 | $77K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,777 | $75K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,798 | $74K |
| 86901 | <1% | 4,411 | $73K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 5,508 | $73K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,457 | $72K |
| 76801 | <1% | 861 | $71K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,622 | $65K |
| 99173 | <1% | 4,510 | $65K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 4,058 | $64K |
| 86480 | <1% | 1,009 | $59K | |
| 87536 | <1% | 1,412 | $57K | |
| 86360 | <1% | 1,347 | $55K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 729 | $54K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 960 | $54K |
| G0008 | Administration of influenza virus vaccine | <1% | 4,268 | $53K |
| 86900 | <1% | 4,382 | $53K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 81 | $52K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,113 | $52K |
| 90686 | <1% | 4,257 | $52K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 4,355 | $49K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 426 | $49K |
| 95819 | <1% | 165 | $49K | |
| 90715 | <1% | 2,218 | $47K | |
| 92550 | <1% | 915 | $47K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 157 | $46K |
| 87806 | <1% | 2,739 | $46K | |
| D0330 | Panoramic radiographic image | <1% | 1,563 | $42K |
| 83655 | <1% | 3,054 | $42K | |
| 0002A | <1% | 1,325 | $42K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 216 | $41K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 260 | $36K |
| 97161 | <1% | 381 | $36K | |
| 88142 | <1% | 1,571 | $35K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 2,891 | $35K |
| 0001A | <1% | 1,277 | $35K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 480 | $35K |
| 99201 | <1% | 494 | $35K | |
| 85027 | <1% | 14,222 | $34K | |
| 83880 | <1% | 1,974 | $33K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 314 | $32K |
| 71045 | Radiologic examination, chest; single view | <1% | 7,978 | $31K |
| 92083 | <1% | 595 | $30K | |
| 90381 | <1% | 62 | $30K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,092 | $29K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,690 | $29K |
| 76830 | Ultrasound, transvaginal | <1% | 445 | $28K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,323 | $28K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 251 | $28K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 285 | $28K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 680 | $28K |
| 99000 | <1% | 1,237 | $27K | |
| 81025 | <1% | 10,906 | $27K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,033 | $27K |
| 90681 | <1% | 2,337 | $27K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,343 | $27K |
| 92133 | <1% | 766 | $26K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,227 | $25K |
| 92587 | <1% | 857 | $24K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 170 | $24K |
| 86780 | <1% | 4,828 | $23K | |
| 36406 | <1% | 1,134 | $23K | |
| 59025 | Fetal non-stress test | <1% | 349 | $23K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 372 | $22K |
| 0012A | <1% | 719 | $21K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,945 | $21K |
| 70486 | <1% | 543 | $21K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,711 | $21K |
| 90837 | Psychotherapy session, about an hour | <1% | 184 | $21K |
| 90698 | <1% | 2,930 | $20K | |
| 90380 | <1% | 44 | $20K | |
| 36000 | <1% | 1,092 | $20K | |
| 90633 | <1% | 1,551 | $19K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,556 | $19K |
| 0011A | <1% | 730 | $18K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,333 | $17K |
| 36591 | <1% | 607 | $17K | |
| 74178 | <1% | 87 | $17K | |
| 87631 | <1% | 517 | $16K | |
| 73630 | <1% | 1,850 | $16K | |
| 12001 | <1% | 41 | $16K | |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 392 | $16K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,252 | $16K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 814 | $15K |
| 81003 | <1% | 13,799 | $15K | |
| 76770 | <1% | 49 | $14K | |
| A0425 | Ground mileage, per statute mile | <1% | 1,511 | $14K |
| 36416 | <1% | 704 | $14K | |
| 86803 | <1% | 2,713 | $13K | |
| 76641 | <1% | 312 | $13K | |
| 85730 | <1% | 6,098 | $12K | |
| 90744 | <1% | 2,008 | $12K | |
| 87340 | <1% | 3,532 | $12K | |
| 99441 | <1% | 241 | $12K | |
| 84439 | <1% | 2,944 | $12K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 44 | $11K |
| 80051 | <1% | 1,211 | $10K | |
| 73610 | <1% | 1,528 | $10K | |
| 90710 | <1% | 1,283 | $10K | |
| 97010 | <1% | 1,443 | $10K | |
| 59430 | <1% | 80 | $10K | |
| 85610 | <1% | 7,238 | $10K | |
| 73562 | <1% | 1,309 | $9K | |
| J1631 | Injection, haloperidol decanoate, per 50 mg | <1% | 573 | $9K |
| 86706 | <1% | 1,716 | $9K | |
| 97116 | <1% | 371 | $9K | |
| 90734 | <1% | 353 | $9K | |
| 92134 | <1% | 182 | $8K | |
| 90648 | <1% | 733 | $8K | |
| 73030 | <1% | 1,193 | $8K | |
| 92579 | <1% | 162 | $8K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 113 | $8K |
| 94726 | <1% | 155 | $8K | |
| 77065 | Tomosynthesis, mammo | <1% | 100 | $8K |
| 76818 | <1% | 99 | $8K | |
| 0004A | <1% | 189 | $8K | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 105 | $7K |
| 90473 | <1% | 2,364 | $7K | |
| 82570 | <1% | 2,656 | $7K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 55 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,451 | $7K |
| 82607 | <1% | 1,103 | $7K | |
| 90658 | <1% | 674 | $7K | |
| 90697 | <1% | 50 | $7K | |
| 81001 | <1% | 8,429 | $7K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 90 | $7K |
| 82728 | <1% | 1,181 | $7K | |
| 84702 | <1% | 2,618 | $6K | |
| 92557 | <1% | 139 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,137 | $6K |
| 82652 | <1% | 302 | $6K | |
| 82248 | <1% | 2,452 | $6K | |
| 99221 | <1% | 57 | $6K | |
| 86704 | <1% | 1,285 | $6K | |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 27 | $6K |
| 72100 | <1% | 501 | $5K | |
| 86769 | <1% | 210 | $5K | |
| 82247 | <1% | 2,008 | $5K | |
| 90746 | <1% | 122 | $5K | |
| 94729 | <1% | 159 | $5K | |
| 99460 | <1% | 57 | $5K | |
| 73130 | <1% | 1,115 | $5K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 38 | $5K |
| 76000 | <1% | 92 | $4K | |
| 88262 | <1% | 84 | $4K | |
| 82746 | <1% | 823 | $4K | |
| 86762 | <1% | 485 | $4K | |
| 0071A | <1% | 104 | $4K | |
| 87077 | <1% | 1,415 | $4K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 436 | $4K |
| 84146 | <1% | 392 | $4K | |
| 01999 | <1% | 2,070 | $4K | |
| 73110 | <1% | 695 | $4K | |
| 87070 | <1% | 992 | $4K | |
| 95117 | <1% | 169 | $4K | |
| 90750 | <1% | 25 | $4K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 512 | $4K |
| 12011 | <1% | 13 | $4K | |
| 90700 | <1% | 559 | $4K | |
| 83970 | <1% | 117 | $3K | |
| 86708 | <1% | 619 | $3K | |
| 86140 | <1% | 1,786 | $3K | |
| 82043 | <1% | 804 | $3K | |
| 94060 | <1% | 24 | $3K | |
| 84156 | <1% | 1,713 | $3K | |
| 83540 | <1% | 1,304 | $3K | |
| 83550 | <1% | 1,330 | $3K | |
| 73590 | <1% | 763 | $3K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 52 | $3K |
| 82533 | <1% | 236 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 109 | $3K |
| 88304 | <1% | 128 | $2K | |
| 87088 | <1% | 1,312 | $2K | |
| 90677 | <1% | 69 | $2K | |
| 86787 | <1% | 446 | $2K | |
| 11721 | <1% | 41 | $2K | |
| 0064A | <1% | 55 | $2K | |
| 73090 | <1% | 510 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,083 | $2K |
| J3490 | Unclassified drugs | <1% | 123 | $2K |
| 83735 | <1% | 7,511 | $2K | |
| 83001 | <1% | 204 | $2K | |
| 99462 | <1% | 52 | $2K | |
| G0009 | Administration of pneumococcal vaccine | <1% | 156 | $2K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 46 | $2K |
| 83615 | <1% | 784 | $2K | |
| 85651 | <1% | 1,837 | $2K | |
| 86255 | <1% | 591 | $2K | |
| 83690 | <1% | 4,466 | $2K | |
| 83002 | <1% | 174 | $2K | |
| 84403 | <1% | 124 | $2K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 12 | $2K |
| 92567 | <1% | 41 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 217 | $2K |
| 92225 | <1% | 51 | $1K | |
| 87186 | <1% | 753 | $1K | |
| 90656 | <1% | 86 | $1K | |
| 97162 | <1% | 14 | $1K | |
| 84100 | <1% | 6,848 | $1K | |
| 76813 | <1% | 15 | $1K | |
| 82550 | <1% | 3,970 | $1K | |
| 80076 | <1% | 123 | $1K | |
| 93246 | <1% | 14 | $1K | |
| 84436 | <1% | 1,213 | $1K | |
| 86376 | <1% | 149 | $1K | |
| 96368 | <1% | 118 | $1K | |
| 84480 | <1% | 398 | $1K | |
| 83021 | <1% | 70 | $1K | |
| 82962 | <1% | 7,811 | $1K | |
| 84153 | <1% | 185 | $1K | |
| 86705 | <1% | 356 | $1K | |
| 82784 | <1% | 168 | $1K | |
| G0010 | Administration of hepatitis b vaccine | <1% | 91 | $1K |
| 82947 | <1% | 6,129 | $1K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 57 | $987.39 |
| 86160 | <1% | 105 | $983.65 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 13 | $961.50 |
| 76536 | <1% | 15 | $880.18 | |
| 92002 | <1% | 12 | $848.94 | |
| 82950 | <1% | 225 | $846.18 | |
| 72170 | <1% | 166 | $816.10 | |
| 11720 | <1% | 12 | $798.30 | |
| 73080 | <1% | 199 | $793.15 | |
| 87081 | <1% | 522 | $761.36 | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 39 | $738.67 |
| 92226 | <1% | 19 | $727.04 | |
| 73560 | <1% | 113 | $724.69 | |
| 86765 | <1% | 59 | $703.48 | |
| 82150 | <1% | 242 | $642.86 | |
| 85045 | <1% | 291 | $618.83 | |
| 86709 | <1% | 213 | $592.54 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,523 | $562.04 |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 40 | $552.84 |
| 86038 | <1% | 189 | $534.81 | |
| 0003A | <1% | 12 | $497.40 | |
| 2010F | <1% | 2,082 | $492.31 | |
| 86703 | <1% | 36 | $491.90 | |
| 73502 | <1% | 52 | $478.58 | |
| 76642 | <1% | 12 | $434.26 | |
| 90707 | <1% | 43 | $433.76 | |
| 4037F | <1% | 3,064 | $420.94 | |
| 90716 | <1% | 25 | $419.50 | |
| 3008F | <1% | 4,570 | $413.19 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,956 | $410.99 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 383 | $408.39 |
| 82465 | <1% | 244 | $402.53 | |
| 82977 | <1% | 118 | $402.40 | |
| 0545F | <1% | 326 | $402.40 | |
| 84484 | <1% | 3,396 | $364.14 | |
| 82105 | <1% | 110 | $364.00 | |
| 84550 | <1% | 172 | $317.47 | |
| 90723 | <1% | 53 | $300.92 | |
| 81511 | <1% | 14 | $300.52 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 1,319 | $295.00 |
| 82552 | <1% | 3,022 | $293.25 | |
| 77073 | <1% | 25 | $290.10 | |
| 87338 | <1% | 51 | $289.16 | |
| 73100 | <1% | 30 | $277.31 | |
| 92202 | <1% | 12 | $273.52 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 43 | $263.63 |
| 85384 | <1% | 91 | $234.47 | |
| 84402 | <1% | 26 | $223.02 | |
| 86735 | <1% | 33 | $214.01 | |
| 81508 | <1% | 12 | $197.55 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 3,418 | $156.89 |
| 87184 | <1% | 27 | $116.86 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,476 | $116.64 |
| 73070 | <1% | 30 | $111.56 | |
| 83520 | <1% | 13 | $108.56 | |
| 90696 | <1% | 15 | $86.92 | |
| 96367 | <1% | 12 | $62.44 | |
| 86593 | <1% | 27 | $58.56 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,604 | $57.94 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 162 | $54.39 |
| 82985 | <1% | 12 | $53.20 | |
| 86364 | <1% | 12 | $46.40 | |
| 96127 | <1% | 31 | $42.00 | |
| 84460 | <1% | 13 | $40.24 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 107 | $36.19 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 673 | $34.51 |
| 85014 | <1% | 112 | $34.00 | |
| 85018 | <1% | 113 | $34.00 | |
| 85041 | <1% | 54 | $33.82 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,381 | $33.00 |
| 73120 | <1% | 12 | $31.19 | |
| 93000 | <1% | 151 | $30.00 | |
| 87040 | <1% | 178 | $24.69 | |
| 73060 | <1% | 25 | $24.55 | |
| 81002 | <1% | 704 | $20.00 | |
| 93041 | <1% | 1,264 | $19.36 | |
| 3089F | <1% | 44 | $18.19 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,471 | $16.16 |
| 83605 | <1% | 297 | $14.82 | |
| 83930 | <1% | 67 | $12.14 | |
| J2704 | Injection, propofol, 10 mg | <1% | 29 | $11.20 |
| 84450 | <1% | 12 | $10.06 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 399 | $9.87 |
| 73140 | <1% | 13 | $7.50 | |
| 85008 | <1% | 50 | $7.46 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 111 | $7.34 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 126 | $3.85 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 71 | $3.24 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 557 | $2.90 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 413 | $2.60 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 209 | $1.96 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 271 | $1.89 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 172 | $1.75 |
| 82009 | <1% | 152 | $1.51 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 306 | $0.72 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 14 | $0.52 |
| 1034F | <1% | 633 | $0.18 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 14 | $0.08 |
| 2022F | <1% | 106 | $0.04 | |
| 3028F | <1% | 167 | $0.01 | |
| 90611 | <1% | 46 | $0.01 | |
| 99080 | 0% | 5,420 | $0.00 | |
| 0502F | 0% | 2,342 | $0.00 | |
| G8506 | Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 0% | 57 | $0.00 |
| 3511F | 0% | 228 | $0.00 | |
| 85378 | 0% | 96 | $0.00 | |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 0% | 1,334 | $0.00 |
| 85007 | 0% | 117 | $0.00 | |
| 3078F | 0% | 31 | $0.00 | |
| 3077F | 0% | 257 | $0.00 | |
| 76376 | 0% | 52 | $0.00 | |
| 1159F | 0% | 31 | $0.00 | |
| 2028F | 0% | 49 | $0.00 | |
| 3085F | 0% | 15 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 242 | $0.00 |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 0% | 85 | $0.00 |
| 3080F | 0% | 79 | $0.00 | |
| 3074F | 0% | 13 | $0.00 | |
| 3066F | 0% | 16 | $0.00 | |
| 73552 | 0% | 24 | $0.00 | |
| 1125F | 0% | 15 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 25 | $0.00 |
| 3079F | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMILLER, RICHARD (CHIEF FINANCIAL OFFICER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.